FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER | Patent Publication Number 20230110113
US 20230110113 A1Publication DateApr 13, 2023
Original Assignee
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsManish MONGA
Mahadi Ali BAIG
Mahadi Ali BAIG
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.